«

»

Jul 28

The revised guidance from the National Institute for Health and Care Excellence (NICE)

The revised guidance from the National Institute for Health and Care Excellence (NICE) recommends once–daily, oral antiplatelet prasugrel, in combination with aspirin, as a cost–effective option in comparison to generic clopidogrel, for a wider group of acute coronary syndrome (ACS) patients having primary or delayed percutaneous coronary intervention (PCI).

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>